Poster Presentation Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2014

Serum vitamin D levels, diabetes and cardiometabolic risk factors in Aboriginal and Torres Strait Islander Australians. (#378)

Louise Maple-Brown 1 2 , Jaqui T Hughes 1 2 , Zhong X Lu 3 4 , Kanakamani Jeyaraman 1 5 , Paul Lawton 1 , Graham RD Jones 6 7 , Andrew Ellis 8 , Ashim Sinha 9 , Alan Cass 1 , Richard MacIsaac 10 11 , George Jerums 8 11 , Kerin O'Dea 5
  1. Menzies school of health research, Casuarina, NT, Australia
  2. Royal Darwin Hospital, Tiwi, NT, Australia
  3. Divisionof Medicine, Monash University, Melbourne
  4. Melbourne Pathology, Melbourne
  5. University of South Australia, Adelaide
  6. SydPath, St Vincents Hospital, Sydney
  7. University of Newsouthwales, Sydney
  8. Austin Health, Melbourne
  9. Cairns Base Hospital and Diabetes Centre, Cairns
  10. St Vincents hospital, Melbourne
  11. University of Melbourne, Melbourne

Low levels of serum 25–hydroxy vitamin D (25(OH)D) have been associated with increased risk of developing type 2 diabetes and cardiovascular disease (CVD), however, there are limited data on serum 25(OH)D in Indigenous Australians, a population at high risk for both diabetes and CVD. We aimed to assess levels of serum 25(OH)D in Aboriginal and Torres Strait Islander Australians and to explore relationships between 25(OH)D and cardio-metabolic risk factors and diabetes.
Methods: 592 Aboriginal and/or Torres Strait Islander Australian participants of The eGFR (estimated glomerular filtration rate) Study, a prospective cross-sectional cohort study performed in 2007-2011, from urban and remote centres within communities, primary care and tertiary hospitals across Northern Territory, Far North Queensland and Western Australia were assessed for serum 25(OH)D and cardio-metabolic risk factors (central obesity, diabetes, hypertension, history of cardiovascular disease, current smoker, low HDL-cholesterol), and diabetes (by history or HbA1c ≥6.5%). Associations were explored between 25(OH)D and outcome measures of diabetes and number of cardio-metabolic risk factors.
The median (IQR) serum 25(OH)D was 60 (45-77) nmol/L, 31% had 25(OH)D <50 nmol/L. For participants with 25(OH)D < 50 vs ≥50 nmol/L, cardio-metabolic risk profile differed for: diabetes (54%, 36% p<0.001), past history of cardiovascular disease (16%, 9%, p=0.014), waist-hip ratio (0.98, 0.92, p<0.001), urine albumin-creatinine ratio (2.7, 1.5 mg/mmol, p<0.001). The OR (95% CI) for diabetes was 2.02 (1.03 – 3.95) for people in the lowest vs highest tertiles of 25(OH)D (<53 vs >72 nmol/L, respectively) after adjusting for known cardio-metabolic risk factors.

Serum 25(OH)D levels <50 nmol/L were highly prevalent among Aboriginal and Torres Strait Islander Australians from Northern and Central Australia. Low 25(OH)D level was associated with adverse cardio-metabolic risk profile and was an independent risk factor for diabetes. These findings require exploration in longitudinal studies.